Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

OBJECTIVE: To describe the course and predictors of glycemic control among patients with type 2 diabetes after sulfonylureas (SUs) are added to metformin (MF). RESEARCH DESIGN AND METHODS: Patients (n = 2,220) treated with MF monotherapy for >90 days before initiating MF plus SU combination...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Cook, M, Girman, C, Stein, P, Alexander, C, Holman, R
Materialtyp:	Journal article
Språk:	English
Publicerad:	2005

Liknande verk

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
av: Hanefeld, M, et al.
Publicerad: (2004)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
av: Turner, R, et al.
Publicerad: (1999)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
av: Turner, R, et al.
Publicerad: (1999)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
av: Cull, C, et al.
Publicerad: (1995)

UKPDS 28: A randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes
av: Wright, A, et al.
Publicerad: (1998)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
av: Zhou, K, et al.
Publicerad: (2011)

Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
av: Zhou, K, et al.
Publicerad: (2011)

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
av: Wright, A, et al.
Publicerad: (2006)

Low branched chain amino acids and tyrosine in Thai patients with type 2 diabetes mellitus treated with metformin and metformin-sulfonylurea combination therapies
av: Sriboonvorakul, N, et al.
Publicerad: (2021)

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
av: Kahn, SE, et al.
Publicerad: (2006)

METFORMIN IN THE MANAGEMENT OF TYPE-2 DIABETES - REPLY
av: Holman, R, et al.
Publicerad: (1989)

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus
av: Newby, D, et al.
Publicerad: (2022)

Quantifying the effect of metformin treatment and dose on glycemic control.
av: Hirst, J, et al.
Publicerad: (2012)

Safety of metformin in Type 2 diabetes mellitus.
av: Baigent, C, et al.
Publicerad: (1999)

DIETARY EVALUATION IN TYPE-II DIABETIC SUBJECTS RANDOMLY ALLOCATED TO INSULIN, SULFONYLUREA OR DIET THERAPY
av: Eeley, E, et al.
Publicerad: (1992)

ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
av: Herman, W, et al.
Publicerad: (2007)

Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects
av: Holman, R, et al.
Publicerad: (1999)

United kingdom prospective diabetes study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy
av: Wright, A, et al.
Publicerad: (1998)

Possible prevention of type 2 diabetes with acarbose or metformin over three years
av: Citroen, H, et al.
Publicerad: (2000)

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
av: Zinman, B, et al.
Publicerad: (2010)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
av: Wright, A, et al.
Publicerad: (2002)

COMPARISON OF TREATMENT OF MILD DIABETES WITH A BASAL INSULIN SUPPLEMENT OR SULFONYLUREA
av: Holman, R, et al.
Publicerad: (1977)

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
av: Lachin, J, et al.
Publicerad: (2011)

Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
av: Holman, R
Publicerad: (2006)

Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes
av: Rama Chandran, Suresh, et al.
Publicerad: (2018)

Metformin as first choice in oral diabetes treatment: the UKPDS experience.
av: Holman, R
Publicerad: (2007)

The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results
av: Levy, J, et al.
Publicerad: (1993)

[The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results]
av: Levy, J, et al.
Publicerad: (1993)

Depressed mood is a factor in glycemic control in type 1 diabetes.
av: Tilburg, V, et al.
Publicerad: (2001)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
av: Stettler, C, et al.
Publicerad: (2006)

Identification of biomarkers for glycaemic deterioration in type 2 diabetes
av: Slieker, Roderick C., et al.
Publicerad: (2023)

Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
av: Huri, Hasniza Zaman, et al.
Publicerad: (2018)

Social support and glycemic control in adult patients with type 2 diabetes mellitus
av: Chew, Boon How, et al.
Publicerad: (2015)

Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes.
av: Belcher, G, et al.
Publicerad: (2005)

Analisa pemilihan Terapi Kombinasi Metformin dengan Penambahan Satu Obat Sulfonylurea pada Pasien Diabetes Melitus Tipe 2 Studi Cross Sectional
av: , OKTAVIAN RIZKI ILAHI, et al.
Publicerad: (2014)

Glycemic control among insulin-treated Type 2 diabetes in Kelantan
av: Ismail, Adibah Hanim, et al.
Publicerad: (2016)

Association of diabetes related self-care activities with glycemic control of patients with type 2 diabetes in Pakistan
av: Bukhsh, Allah, et al.
Publicerad: (2018)

Dietary glycemic index, glycemic load, and digestible carbohydrate intake are not associated with risk of type 2 diabetes in eight European countries.
av: Sluijs, I, et al.
Publicerad: (2013)

Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
av: Clarke, P, et al.
Publicerad: (2001)

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
av: Turner, R, et al.
Publicerad: (1998)